Print Page     Close Window     

SEC Filings

6-K
IKANG HEALTHCARE GROUP, INC. filed this Form 6-K on 12/21/2018
Entire Document
 

 

“Since the successful launch of iKangCare+ and iKangPartners+ plans in fiscal 2017, we have made significant strides in leveraging these initiatives to further diversify revenue streams and have yielded promising results over the past few quarters.  We are also advancing several new initiatives to deepen our focus in areas of Ai through iKangAi+ and partnership with public hospitals through iKangNetwork+, which were initiatives recently launched in Beijing, Shanghai and Guangzhou” said Mr. Zhang. “We expect the impact of these efforts to accelerate through the remaining of fiscal 2018 and beyond. Our strategy is focused on placing our customers at the center of everything we do and I am very pleased with our progress in continuing to deliver increasing value at an accelerating pace to the millions of customers we serve, helping them live healthier lives and helping make the healthcare system work better for everyone.”

 

“We are very excited of the enormous opportunities presented to us in the private preventive healthcare industry in China. As we look forward, we will drive our growth on the strength of practical innovation that anticipates and responds to increasing customer expectations and needs. We believe we are on solid trajectory to build on our continuous success and commitment to advancing our growth strategies that aim to deliver long-term and sustainable returns to our shareholders.”

 

FISCAL SECOND QUARTER ENDED SEPTEMBER 30, 2018 UNAUDITED FINANCIAL RESULTS

 

Net Revenues (4)

 

Net revenues for the fiscal second quarter were US$177.7 million, representing a 16.6% increase from US$152.4 million in the same period of the last fiscal year. On a RMB basis, the revenue growth was 19.0% compared to the fiscal second quarter of 2017. As of September 30, 2018, the number of self-owned medical centers totaled 115 compared to 110 as of September 30, 2017. In this quarter, the Company served approximately a total of 2.10 million customer visits under both corporate and individual programs, representing an increase of 15.0% compared to the fiscal second quarter of 2017.

 

The table below sets forth a breakdown of net revenues:

 

(US$ million)

 

Fiscal Second Quarter
Ended September 30, 2018

 

Fiscal Second Quarter
Ended September 30, 2017

 

YoY % Change

 

Medical Examinations

 

139.6

 

122.0

 

14.4

%

Disease Screening

 

20.5

 

14.8

 

38.7

%

Dental Services

 

4.6

 

4.6

 

0.8

%

Other Services

 

13.0

 

11.0

 

18.1

%

Total

 

177.7

 

152.4

 

16.6

%

 

Medical Examinations: Net revenues for the quarter were US$139. 6 million, representing a 14.4% increase from US$122.0 million in the same period of the last fiscal year.

 

Disease Screening: Net revenues for the quarter were US$20.5 million, representing a 38.7% increase from US$14.8 million in the same period of the last fiscal year. Disease screening services refer to the additional services requested by individuals under the basic corporate medical examination programs as a result of individual needs.

 


(4)         iKang adopted ASC 606 by using modified retrospective method since April 1, 2018. The impact of applying this ASC is insignificant.

 

2



Copyright © 2015- iKang Healthcare Group, Inc. All Rights Reserved.